Click here for more information about Ritonavir [clinicaltrials_resource:45395fbdbc367b4740e6dc7e8b3cbd16]
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells [clinicaltrials:NCT00000822]A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 [clinicaltrials:NCT00000859]Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315 [clinicaltrials:NCT00000891]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients [clinicaltrials:NCT00000906]A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children [clinicaltrials:NCT00000913]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [clinicaltrials:NCT00000940]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients [clinicaltrials:NCT00001075]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection [clinicaltrials:NCT00006339]Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication [clinicaltrials:NCT00006578]Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment [clinicaltrials:NCT00012519]Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV [clinicaltrials:NCT00027339]Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [clinicaltrials:NCT00028366]clinicaltrials:NCT00051831clinicaltrials:NCT00118898clinicaltrials:NCT00811954
link [clinicaltrials_vocabulary:link]
Click here for more information about Ritonavir [clinicaltrials_resource:45395fbdbc367b4740e6dc7e8b3cbd16]
Bio2RDF identifier
45395fbdbc367b4740e6dc7e8b3cbd16
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:45395fbdbc367b4740e6dc7e8b3cbd16
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:45395fbdbc367b4740e6dc7e8b3cbd16
title
Click here for more information about Ritonavir
@en
Click here for more information about ritonavir
@en
Click here for more information on ritonavir
@en
type
label
Click here for more informatio ...... 95fbdbc367b4740e6dc7e8b3cbd16]
@en
Click here for more informatio ...... 95fbdbc367b4740e6dc7e8b3cbd16]
@en
Click here for more informatio ...... 95fbdbc367b4740e6dc7e8b3cbd16]
@en